pirfenidone has been researched along with Cicatrix, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, KP; Wells, AR | 1 |
| Armendariz-Borunda, J; Armendariz-Vazquez, O; Bautista, CA; Flores-Montana, J; Floresvillar-Mosqueda, J; Garcia-Rocha, S; Godoy, J; Gonzalez-García, I; Lucano-Landeros, MS; Lyra-Gonzalez, I; Magaña-Castro, R; Martinez-Fong, D; Medina-Preciado, D; Miranda, RA; Peña-Santoyo, P; Sanchez-Parada, MG; Vazquez-Del Mercado, M | 1 |
1 trial(s) available for pirfenidone and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
A controlled clinical trial with pirfenidone in the treatment of pathological skin scarring caused by burns in pediatric patients.
Topics: Administration, Cutaneous; Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Burns; Child; Child, Preschool; Cicatrix, Hypertrophic; Compression Bandages; Drug Administration Schedule; Female; Gels; Humans; Male; Pilot Projects; Prospective Studies; Pyridones; Treatment Outcome | 2012 |
1 other study(ies) available for pirfenidone and Cicatrix, Hypertrophic
| Article | Year |
|---|---|
Pirfenidone attenuates the profibrotic contractile phenotype of differentiated human dermal myofibroblasts.
Topics: Adult; Cell Differentiation; Cells, Cultured; Cicatrix, Hypertrophic; Extracellular Matrix; Fibrosis; Humans; Myofibroblasts; Pyridones; Skin; Transforming Growth Factor beta1 | 2020 |